Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.112621
Revised: September 13, 2025
Accepted: November 28, 2025
Published online: January 15, 2026
Processing time: 166 Days and 13.2 Hours
The stress hyperglycemia ratio (SHR) reflects patients’ acute hyperglycemia status, and the time in range (TIR) captures glucose control dynamics during their intensive care unit (ICU) stays.
To investigate the independent and combined associations of SHR and TIR with 28-day mortality among surgical ICU patients.
In total, 706 adult patients with available glucose data were included. SHR was calculated as the ratio of admission glucose levels to glycosylated hemoglobin-derived estimated average glucose. TIR was calculated as percentages of glucose readings within the 3.9-10.0 mmol/L range during the ICU stay. SHR and TIR were divided into quartiles, and patients were allocated to four groups according to combinations of high/low values. The associations of the SHR, TIR, and both combined with mortality were assessed using logistic regression.
Logistic regression analysis demonstrated that patients in the highest SHR quartile had a significantly increased risk of 28-day mortality compared with the reference quartile [adjusted odds ratio (OR) = 2.24; 95% confidence interval (CI): 1.06-4.71; P = 0.033]. In contrast, higher TIR were associated with a reduced risk of 28-day mortality. Compared with the lowest TIR quartile (Q1), adjusted ORs in Q2, Q3, and Q4 were 0.43 (95%CI: 0.23-0.93; P = 0.030), 0.43 (95%CI: 0.19-0.99; P = 0.046), and 0.41 (95%CI: 0.17-0.98; P = 0.045), respectively. When the SHR and TIR were analyzed in combination, patients with high SHR and low TIR had the highest risk of 28-day mortality (adjusted OR = 2.19; 95%CI: 1.05-4.58; P = 0.038).
Combined SHR and TIR assessment offers prognostic value in surgical ICU patients. Maintaining glucose within the target range may be important to improve short-term outcomes in patients with stress hyperglycemia.
Core Tip: While the stress hyperglycemia ratio (SHR) has been widely examined as a marker of acute glycemic disturbance, prior studies have largely emphasized its independent prognostic value, often neglecting its interaction with longitudinal glycemic control indicators. In this study, we evaluated the combined effect of SHR and time in range (TIR) on 28-day mortality in surgical ICU patients. We found that patients with both elevated SHR and reduced TIR exhibited the highest risk of death, with a 2.37-fold increase compared to those with low SHR and high TIR. These findings highlight the prognostic relevance of both acute hyperglycemia and persistent glycemic dysregulation, and emphasize the potential value of integrated glucose management strategies in critically ill patients.
